Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CMS✓SelectedUSD · CMSMRNA vs CMS performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs CMS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
CMS return
+34.7%
Excess return
+112.3%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCMSExcessAlpha
1D-2.2%+0.8%-3.0%-2.0%
7D-12.7%-0.4%-12.3%-12.7%
30D-20.7%+3.8%-24.4%-20.0%
3M+46.3%+1.2%+45.0%+47.4%
6M+305.2%-2.3%+307.6%+308.8%
YTD+561.2%+3.5%+557.8%+563.7%
1Y+772.1%-1.6%+773.7%+781.1%
3Y+147.0%+34.8%+112.1%+130.4%
All+147.0%+34.7%+112.3%+130.4%

Cumulative growth

Daily Returns

Daily percentage return beside CMS.

Daily Out/Under-Performance

Portfolio return minus CMS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CMS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CMS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling